WMA Declaration of Helsinki – Ethical Principles f... ...
Drug candidate slows motor neuron disease progress...
NAD⁺ restores memory in Alzheimer's disease models...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Young adults commonly mix cannabis with nicotine and tobacco...
April 06,2026
You finally got a doctor's appointment. Here's how to get th...
April 05,2026
Thick melanoma tumors may be linked to poorer survival than ...
April 04,2026
Study demonstrates how pediatric integrative medicine can be...
April 03,2026
Sodium bicarbonate fails to boost survival in patients with ...
April 02,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Announcement of the 2025 Nobel Prize in ...
Can a twice-a-year shot help end the HIV...
Reprogramming Stem Cells Could Cure Type...
Dr. Fauci among hundreds who've contract...
More News
Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease

Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease

byCase Western Reserve UniversityCredit: SHVETS production from PexelsResearchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs,
Neurology November 07,2024
Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease

Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease

byCase Western Reserve UniversityCredit: SHVETS production from PexelsResearchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs,
Neurology November 07,2024
New anti-obesity drug shows promise in preventing heart failure related to type 2 diabetes

New anti-obesity drug shows promise in preventing heart failure related to type 2 diabetes

by Gillian Rutherford,University of AlbertaGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114573A University of Alberta pharmacology researcher has discove
Cardiovascular Diseases November 07,2024
New anti-obesity drug shows promise in preventing heart failure related to type 2 diabetes

New anti-obesity drug shows promise in preventing heart failure related to type 2 diabetes

by Gillian Rutherford,University of AlbertaGraphical abstract. Credit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.114573A University of Alberta pharmacology researcher has discove
Cardiovascular Diseases November 07,2024
FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a
Oncology November 07,2024
FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

FDA approves Vyloy for advanced gastric or gastroesophageal junction cancer

by Lori SolomonThe U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of a
Oncology November 07,2024
Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer

Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainDrugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer
OB & GYN November 07,2024
Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer

Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainDrugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer
OB & GYN November 07,2024
Repurposing mifepristone: New hope for anti-aging treatments

Repurposing mifepristone: New hope for anti-aging treatments

byUniversity of Southern CaliforniaA single live adult Drosophila expressing the mito-QC mitophagy reporter. A greater red-to-green ratio indicates greater mitophagy. Credit: John Tower/USC Dorn
Geriatrics November 07,2024
Repurposing mifepristone: New hope for anti-aging treatments

Repurposing mifepristone: New hope for anti-aging treatments

byUniversity of Southern CaliforniaA single live adult Drosophila expressing the mito-QC mitophagy reporter. A greater red-to-green ratio indicates greater mitophagy. Credit: John Tower/USC Dorn
Geriatrics November 07,2024
New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

by Stephanie Baum , Medical XpressCredit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.2024.1484040Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well
Neurology November 07,2024
New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

New review suggests evaluating Tibetan medicinal herb as potential treatment for mild cognitive impairment

by Stephanie Baum , Medical XpressCredit:Frontiers in Pharmacology(2024). DOI: 10.3389/fphar.2024.1484040Within Tibetan medicine, the medicinal herb Terminalia chebula (T. chebula) is well
Neurology November 07,2024
The decision to eat may come down to these three neurons

The decision to eat may come down to these three neurons

by Katherine Fenz,Rockefeller UniversityVMHBDNFneurons suppress food intake and body weight. Credit:Nature(2024). DOI: 10.1038/s41586-024-08098-1Speaking, singing, coughing, la
Neurology November 07,2024
The decision to eat may come down to these three neurons

The decision to eat may come down to these three neurons

by Katherine Fenz,Rockefeller UniversityVMHBDNFneurons suppress food intake and body weight. Credit:Nature(2024). DOI: 10.1038/s41586-024-08098-1Speaking, singing, coughing, la
Neurology November 07,2024
Brain pathways that control dopamine release may influence motor control

Brain pathways that control dopamine release may influence motor control

by Anne Trafton,Massachusetts Institute of TechnologyStriosomal S-D1 and S-D2 populations form parallel pathways to dopamine-containing nigral neurons. Credit:Current Biology(2024).
Neurology November 07,2024
Brain pathways that control dopamine release may influence motor control

Brain pathways that control dopamine release may influence motor control

by Anne Trafton,Massachusetts Institute of TechnologyStriosomal S-D1 and S-D2 populations form parallel pathways to dopamine-containing nigral neurons. Credit:Current Biology(2024).
Neurology November 07,2024
Brain organoids reveal autism biology and potential treatments

Brain organoids reveal autism biology and potential treatments

byThe Scripps Research InstituteA cerebral organoid showing rosettes (or whirls) of newly developing and migrating new neurons (shown in purplish-red). Credit: Scripps ResearchUsing stem cells g
Neurology November 07,2024
Brain organoids reveal autism biology and potential treatments

Brain organoids reveal autism biology and potential treatments

byThe Scripps Research InstituteA cerebral organoid showing rosettes (or whirls) of newly developing and migrating new neurons (shown in purplish-red). Credit: Scripps ResearchUsing stem cells g
Neurology November 07,2024
Decoding the hidden signals of aggression and arousal in the brain

Decoding the hidden signals of aggression and arousal in the brain

byCalifornia Institute of TechnologyAttractor dynamics in head-fixed mice observing aggression. Credit:Nature(2024). DOI: 10.1038/s41586-024-07915-xA series of three papers from neur
Neurology November 07,2024
Decoding the hidden signals of aggression and arousal in the brain

Decoding the hidden signals of aggression and arousal in the brain

byCalifornia Institute of TechnologyAttractor dynamics in head-fixed mice observing aggression. Credit:Nature(2024). DOI: 10.1038/s41586-024-07915-xA series of three papers from neur
Neurology November 07,2024
More News
Week’s Top
Podcasts
... Can AI Catch What Doctors Miss? ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Health spending has been rising across rich countries with different systems ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com